Claims
- 1. A container, tube, or medical tool with improved resistance to sterilizing radiation formed by the process of:
- a. preparing a polymer comprising at least 50% of units derived from one or more alkyl methacrylate monomers and, optionally, one or more other monomers selected from vinyl or vinylidene monomers;
- b. admixing the polymer with up to about 50 weight percent, based on the polymer, of an impact modifier for the polymer;
- c. admixing the polymer-impact modifier mixture with from about 0.25 to about two percent by weight of the polymer of at least one .alpha.-hydroxyacid, no ultraviolet stabilizer being present, so as to distribute the .alpha.-hydroxyacid essentially uniformly throughout the polymer;
- d. forming the polymer-impact modifier-.alpha.-hydroxyacid mixture into a container, tube, or medical tool.
- 2. The container, tube or medical tool of claim 1 wherein the .alpha.-hydroxyacid is lactic acid and the amount is from about 0.25 to less than 0.5 percent by weight of the polymer.
- 3. A sterilized container, tube, or medical tool prepared by the process of:
- a. preparing a polymer comprising at least 50% of units derived from one or more alkyl methacrylate monomers and, optionally, one or more other monomers selected from vinyl or vinylidene monomers;
- b. admixing the polymer with up to about 50 weight percent, based on the polymer, of an impact modifier for the polymer;
- c. admixing the polymer-impact modifier mixture with from about 0.25 to about two percent by weight of the polymer of at least one .alpha.-hydroxyacid, no ultraviolet stabilizer being present, so as to distribute the .alpha.-hydroxyacid essentially uniformly throughout the polymer;
- d. forming the polymer-impact modifier-.alpha.-hydroxyacid mixture into a container, tube, or medical tool;
- e. exposing the container, tube, or medical tool to at least about 3 megarads of gamma irradiation or to at least about 2.5 megarads of elctron beam sterilizing radiation.
- 4. The container, tube or medical tool of claim 3 wherein the .alpha.-hydroxyacid is lactic acid and the amount is from about 0.25 to less than 0.5 percent by weight of the polymer.
- 5. The container, tube, or medical tool of claim 1 wherein the impact modifier is a core/shell polymer containing a core primarily of units derived from butyl acrylate.
- 6. The container, tube, or medical tool of claim 5 wherein the impact modifier is a core/shell polymer containing a hard core predominantly of units derived from methyl methacrylate, and intermediate stage predominantly of units derived from butyl acrylate, and a shell predominantly of units derived from methyl methacrylate.
- 7. The container, tube, or medical tool of claim 1 wherein the polymer prior to addition of the impact modifier and the .alpha.-hydroxyacid is in molten form or in solution.
- 8. The container, tube, or medical tool of claim 7 wherein the temperature of the admixture of the impact modifier and of the .alpha.-hydroxyacid is from about 200.degree. C. to about 250.degree. C.
- 9. A container, tube, or medical tool with improved resistance to sterilizing radiation formed by the process of:
- a. preparing a polymer comprising at least 50% of units derived from one or more alkyl methacrylate monomers and, optionally, one or more other monomers selected from vinyl or vinylidene monomers;
- b. admixing the polymer with up to about 50 weight percent, based on the polymer, of an impact modifier for the polymer;
- c. admixing the polymer-impact modifier mixture with from about one-half to about two percent by weight of the polymer of an ester of an .alpha.-hydroxyacid, the ester containing from above 10 to 25 carbon atoms, no ultraviolet stabilizer being present, so as to distribute the ester essentially uniformly throughout the polymer;
- d. forming the polymer-impact modifier-ester mixture into a container, tube, or medical tool.
- 10. The container, tube or medical tool of claim 9 wherein the ester of the .alpha.-hydroxyacid is lauryl lactate.
- 11. A sterilized container, tube, or medical tool prepared by the process of:
- a. preparing a polymer comprising at least 50% of units derived from one or more alkyl methacrylate monomers and, optionally, one or more other monomers selected from vinyl or vinylidene monomers;
- b. admixing the polymer with up to about 50 weight percent, based on the polymer, of an impact modifier for the polymer;
- c. admixing the polymer-impact modifier mixture with from about one-half to about two percent by weight of the polymer of at least one ester of an .alpha.-hydroxyacid, the ester containing from above 10 to 25 carbon atoms, no ultraviolet stabilizer being present, so as to distribute the ester essentially uniformly throughout the polymer;
- d. forming the polymer-impact modifier-ester mixture into a container, tube, or medical tool;
- e. exposing the container, tube, or medical tool to at least about 5 megarads of gamma irradiation or to at least 2.5 megarads of electron beam sterilizing radiation.
Parent Case Info
This is a continuation-in-part of U.S. application Ser. No. 07/988,644, filed Dec. 10, 1992, which is a division of U.S. application Ser. No. 07/751,421, filed Aug. 28, 1991, now U.S. Pat. No. 5,216,060, which is a division of U.S. Ser. No. 07/499,104, filed Mar. 26, 1990 now U.S. Pat. No. 5,102,940.
US Referenced Citations (10)
Foreign Referenced Citations (1)
Number |
Date |
Country |
2169298 |
Dec 1985 |
GBX |
Non-Patent Literature Citations (2)
Entry |
On the Mechanism of Polymer Destruction under UV and Gamma Irradiation: The Influence of Low Molecular Weight Additives Related to Vibrational Cross-Relaxation, AS Belichenkol et al., Sixth Symposium on Radiation Chemistry (1986), pp. 535,538. |
Effect of Low-Molecular-Weight Additives on the Radiation Strength of Transparent Polymers, E. Eremeeva et al., Sov. J. Opt. Technol., vol. 53, No. 6, Jun. 1986, pp. 361-362. |
Divisions (2)
|
Number |
Date |
Country |
Parent |
751421 |
Aug 1991 |
|
Parent |
499104 |
Mar 1990 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
988644 |
Dec 1992 |
|